These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34236433)
41. Hepcidin and iron status in pregnant women and full-term newborns in first days of life. Kulik-Rechberger B; Kościesza A; Szponar E; Domosud J Ginekol Pol; 2016; 87(4):288-92. PubMed ID: 27321101 [TBL] [Abstract][Full Text] [Related]
42. Erythroferrone contributes to recovery from anemia of inflammation. Kautz L; Jung G; Nemeth E; Ganz T Blood; 2014 Oct; 124(16):2569-74. PubMed ID: 25193872 [TBL] [Abstract][Full Text] [Related]
43. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia. Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344 [TBL] [Abstract][Full Text] [Related]
44. Analytical and biological assessment of circulating human erythroferrone. Appleby S; Chew-Harris J; Troughton RW; Richards AM; Pemberton CJ Clin Biochem; 2020 May; 79():41-47. PubMed ID: 32032568 [TBL] [Abstract][Full Text] [Related]
45. Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis. Cercamondi CI; Stoffel NU; Moretti D; Zoller T; Swinkels DW; Zeder C; Mhimibra F; Hella J; Fenner L; Zimmermann MB Blood; 2021 Oct; 138(15):1293-1303. PubMed ID: 33876222 [TBL] [Abstract][Full Text] [Related]
46. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents. Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222 [TBL] [Abstract][Full Text] [Related]
47. Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone. Hanudel MR; Wong S; Jung G; Qiao B; Gabayan V; Zuk A; Ganz T Kidney Int; 2021 Jul; 100(1):79-89. PubMed ID: 33811979 [TBL] [Abstract][Full Text] [Related]
48. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665 [TBL] [Abstract][Full Text] [Related]
49. Maternal Iron Status Is Dynamic Throughout Pregnancy and Might Predict Birth Outcomes in a Sex Dependent Manner: Results from the Alberta Pregnancy Outcomes and Nutrition (APrON) Cohort Study. Evanchuk JL; Kozyrskyj A; Hanas N; Goruk S; Vaghef-Mehrabani E; Archundia-Herrera CM; O'Brien KO; Letourneau NL; Giesbrecht GF; Bell RC; Field CJ J Nutr; 2023 Sep; 153(9):2585-2597. PubMed ID: 37393033 [TBL] [Abstract][Full Text] [Related]
50. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice. Coffey R; Sardo U; Kautz L; Gabayan V; Nemeth E; Ganz T Physiol Rep; 2018 Sep; 6(19):e13890. PubMed ID: 30315639 [TBL] [Abstract][Full Text] [Related]
51. Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients. Limm-Chan B; Wesseling-Perry K; Pearl MH; Jung G; Tsai-Chambers E; Weng PL; Hanudel MR Pediatr Nephrol; 2021 Oct; 36(10):3241-3249. PubMed ID: 33903951 [TBL] [Abstract][Full Text] [Related]
52. Maternal Overweight and Obesity during Pregnancy Are Associated with Neonatal, but Not Maternal, Hepcidin Concentrations. Jones AD; Shi Z; Lambrecht NJ; Jiang Y; Wang J; Burmeister M; Li M; Lozoff B J Nutr; 2021 Aug; 151(8):2296-2304. PubMed ID: 33979838 [TBL] [Abstract][Full Text] [Related]
53. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs]. Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526 [TBL] [Abstract][Full Text] [Related]
54. Erythroferrone Expression in Anemic Rheumatoid Arthritis Patients: Is It Disordered Iron Trafficking or Disease Activity? Youssef SR; Hassan EH; Morad CS; Elazab Elged AA; El-Gamal RA J Inflamm Res; 2021; 14():4445-4455. PubMed ID: 34522114 [TBL] [Abstract][Full Text] [Related]
56. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study. Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328 [TBL] [Abstract][Full Text] [Related]
57. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707 [TBL] [Abstract][Full Text] [Related]
58. Iron stores at birth in a full-term normal birth weight birth cohort with a low level of inflammation. Zhang JY; Wang J; Lu Q; Tan M; Wei R; Lash GE Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245095 [TBL] [Abstract][Full Text] [Related]
59. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly. Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735 [TBL] [Abstract][Full Text] [Related]
60. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease. Mangaonkar AA; Thawer F; Son J; Ajebo G; Xu H; Barrett NJ; Wells LG; Bowman L; Clair B; Patel N; Bora P; Jung G; Nemeth E; Kutlar A Br J Haematol; 2020 Jun; 189(6):1204-1209. PubMed ID: 32030737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]